Ispire Technology (ISPR) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Engaged in R&D, design, commercialization, sales, and distribution of branded e-cigarettes and cannabis vaping products, with tobacco products sold globally (excluding PRC, US, Russia) and cannabis vaping hardware sold in the US, recently expanding to Canada and Europe.
Products marketed under Aspire (tobacco) and Ispire (cannabis) brands, with cannabis hardware primarily sold on an ODM basis to other vapor companies.
Proprietary technologies include BDC and BVC coil systems, Cleito tank, and patented DuCore and Ispire ONE technologies for improved performance and safety.
Majority of manufacturing is outsourced to Shenzhen Yi Jia, with new in-house manufacturing facility in Malaysia operational since February 2024, focusing on assembly and ISO/GMP certified.
Global distribution network covers over 30 countries with more than 150 distributors, primary markets in Europe and Asia Pacific.
Use of proceeds and capital allocation
Net proceeds intended for general corporate purposes, including working capital and potential acquisitions synergistic with current technologies, though no specific acquisition is planned.
Pending use, proceeds will be invested in short-term, investment-grade securities.
Risk factors and disclosures
Investment involves a high degree of risk, with risks detailed in the prospectus supplement and incorporated SEC filings.
Additional risks may exist beyond those currently known or considered material.
Latest events from Ispire Technology
- FY2025 revenue hit $127.5M, fueled by tech innovation and global expansion.ISPR
Investor presentation13 Feb 2026 - Revenue fell 51.5% but cost controls narrowed losses and set up future growth.ISPR
Q2 20269 Feb 2026 - Record revenue and margin gains, but net loss widened; global nicotine growth drives FY2025 outlook.ISPR
Q4 202420 Jan 2026 - Gross margin rose to 19.5% as profit improved, but revenue fell and losses widened.ISPR
Q1 202515 Jan 2026 - Shareholders will vote on director elections, auditor ratification, and key governance matters.ISPR
Proxy Filing2 Dec 2025 - Gross margin rose to 18.5% on flat revenue, but net loss widened amid global expansion.ISPR
Q2 20251 Dec 2025 - Q3 revenue dropped 12.7% to $26.2M as losses widened and Malaysia shift aims to cut costs.ISPR
Q3 202526 Nov 2025 - Revenue down 22.8% to $30.4M, net loss narrows, and cost controls improve EBITDA.ISPR
Q1 202613 Nov 2025 - Proprietary age-gating tech and Malaysia expansion position the firm for global growth.ISPR
Planet MicroCap Showcase: TORONTO 202522 Oct 2025